Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice
Baicalein schützt vor wiederholtem unvorhersehbarem stressinduziertem depressionsähnlichem Verhalten bei Mäusen
Pharmacopsychiatry · 03.11.2026
DOI: 10.1055/a-2975-3128 ↗Auf einen Blick
Bei Mäusen verringerte Baicalein stressinduzierte depressions- und angstartige Verhaltensweisen. Zudem stiegen Serotonin, Dopamin, cAMP und die BDNF-mRNA in Hippocampus und Kortex.
Fragestellung
Schützt Baicalein bei Mäusen vor durch chronischen Stress ausgelöstem depressions- und angstartigem Verhalten?
Methode
Mäuse erhielten Baicalein 10, 20 oder 40 mg/kg intraperitoneal 30 Minuten vor täglichem unvorhersehbarem Stress über 14 Tage. Verhalten wurde mit Tail-Suspension-Test, Forced-Swimming-Test, Novelty-Suppressed-Feeding-Test und Sucrose-Preference-Test geprüft.
Ergebnisse
Baicalein senkte die Immobilitätsdauer im Forced-Swimming-Test und Tail-Suspension-Test, erhöhte die Saccharoseaufnahme und verkürzte die Latenz bis zur Nahrungsaufnahme. Serotonin und Dopamin stiegen, MAO-Aktivität sank.
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass Baicalein Mäuse vor stressbedingten depressions- und angstartigen Verhaltensweisen schützen kann, möglicherweise über erhöhte Monoaminspiegel sowie cAMP und BDNF.
Kernaussagen
- Weniger Immobilität im Forced-Swimming-Test und Tail-Suspension-Test
- Mehr Saccharoseaufnahme, kürzere Latenz bis zur Nahrungsaufnahme
- Serotonin, Dopamin und cAMP stiegen; MAO-Aktivität sank
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Pharmacopsychiatry, online erschienen am 03.11.2026. Verfasst von Dingzhong Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai University of Medicine and Health Sciences, Affiliated Jinshan District Central Hospital, China, Shanghai. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Baicalein, an active flavonoid derived from the root of Scutellaria baicalensis, has been extensively utilized in the treatment of stress-related neuropsychiatric disorders, encompassing behaviors indicative of depression and anxiety. The precise neurochemical and molecular biological mechanisms underlying the effect of baicalein on depression-like behavior have yet to be elucidated. In the current study, mice were administered baicalein at dosages of 10, 20, or 40 mg/kg (intraperitoneally) 30 minutes before being subjected to daily exposure to unpredictable stress over a period of 14 days. The tail suspension test and the forced swimming test, along with the novelty suppressed feeding test and the sucrose preference test, were employed to assess the protective effects of baicalein against depression- and anxiety-like behaviors induced by chronic stress. The outcomes indicated that baicalein notably reduced the duration of immobility in both the forced swimming test and tail suspension test, elevated sucrose consumption, and diminished the latency to feed, thereby reflecting its antidepressant and anxiolytic properties. Additionally, baicalein elevated the concentrations of serotonin and dopamine and suppressed monoamine oxidase activity within the hippocampus and cortex of stressed mice. Following baicalein treatment, the levels of cyclic adenosine monophosphate and the messenger RNA expression of the brain-derived neurotrophic factor were also observed to increase in these brain regions. These results suggest that baicalein may safeguard mice from depression- and anxiety-like behaviors precipitated by chronic stress, potentially through the augmentation of monoamine levels by inhibiting monoamine oxidase activity, and by stimulating the production of cyclic adenosine monophosphate and brain-derived neurotrophic factor in brain areas implicated in emotional disorders. Baicalein could prove to be a significant agent for the prevention or mitigation of the multifaceted symptoms associated with depression and anxiety.
Autor:innen und Institutionen
- Shanghai University of Medicine and Health Sciences, Affiliated Jinshan District Central Hospital, China, Shanghai.
- Nanjing Medical University, Medical Center of Trauma, the Affiliated Changzhou No. 2 People's Hospital, Jiangsu, China, Nanjing.
- Westlake University, Department of Pharmacy, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang, China, Hangzhou.
- Shanghai University, Medicine and Health Sciences, Affiliated Jinshan District Central Hospital, China, Shanghai.
- Shanghai Pudong New Area People's Hospital Shanghai, Department of Emergency and Critical Care Medicine, China, Shanghai.
- Affiliated Hangzhou First People's Hospital, Department of Traditional Chinese Medicine Pharmacy, School of Medicine, Westlake University, China, Hangzhou.
ORCID-Profile: Min Zhou
Zitieren
APA
Tang, D., Shi, Y., Zhou, W., Chen, L., Lin, N., Liang, Y., Jiang, Y., Chuan, H., Liu, N., Wan, J., & Zhou, M. (2026). Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice. Pharmacopsychiatry. https://doi.org/10.1055/a-2975-3128
Vancouver
Tang D, Shi Y, Zhou W, Chen L, Lin N, Liang Y, et al. Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice. Pharmacopsychiatry. 2026. doi:10.1055/a-2975-3128
BibTeX
@article{Tang2026,
author = {Tang, Dingzhong and Shi, Yongchuan and Zhou, Weibo and Chen, Ling and Lin, Naichao and Liang, Yuping and Jiang, Yan and Chuan, He and Liu, Na and Wan, Jian and Zhou, Min},
title = {Baicalein Protects against Repeated Unpredictable Stress-Induced Depression-like Behavior in Mice},
journal = {Pharmacopsychiatry},
year = {2026},
doi = {10.1055/a-2975-3128}
}
EUVIMED